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controls (6.3 [2] vs. 3.9 [1.9] ng/mg Cholesterol; p = 0.004). 24S-HC
and 27-HC levels were respectively ﬁve and 20-fold higher in the
arterial tissue of PAD individuals than in those of the controls
(p = 0.016 and p = 0.001). Plasma C-reactive protein correlated
with plasma 24S-HC (r = 0.51; p = 0.010), 25-HC (r = 0.75;
p b 0.001), 27-HC (r = 0.48; p = 0.015), and with tissue 24S-HC
(r = 0.40; p = 0.041) and 27-HC (r = 0.46; p = 0.023). Conclusion:
The accumulation in the arterial intima of oxysterols originated
enzymatically, and not by the action of free radicals, is associated
with the severity of atherosclerotic disease and of the systemic
inﬂammatory activity in individuals with severe PAD.
doi:10.1016/j.bbacli.2015.05.036
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HDL size is more accurate than HDL cholesterol to predict carotid
subclinical atherosclerosis in individuals classiﬁed as low cardio-
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Background: Misclassiﬁcation of patients as low cardiovascular
risk (LCR) remains a major concern and challenges the efﬁcacy of
traditional risk markers. Due to its strong association with choles-
terol acceptor capacity, high-density lipoprotein (HDL) size has been
appointed as a potential risk marker. Hence, we investigate whether
HDL size improves the predictive value of HDL-cholesterol in the
identiﬁcation of carotid atherosclerotic burden in individuals strat-
iﬁed to be at LCR. Methods: 284 individuals (40–75 years) classiﬁed
as LCR by the current US guidelines were selected in a three-step
procedure from primary care centers of the cities of Campinas and
Americana, SP, Brazil. Apolipoprotein B-containing lipoproteins were
precipitated by polyethylene glycol and HDL size was measured by
dynamic light scattering (DLS) technique. Participants were classiﬁed
in tertiles of HDL size (b7.57; 7.57–8.22; N8.22 nm). Carotid intima–
media thickness (cIMT) b0.90 mm (80th percentile) was determined
by high resolution ultrasonography and multivariate ordinal regres-
sion models were used to assess the association between cIMT across
HDL size and levels of lipid parameters. Results: HDL-cholesterol was
not associated with cIMT. In contrast, HDL size N8.22 nm was
independently associated with low cIMT in either unadjusted and
adjusted models for age, gender and Homeostasis Model Assessment
2 index for insulin sensitivity, ethnicity and body mass index (odds
ratio 0.23; 95% conﬁdence interval 0.07–0.74, p = 0.013). Conclu-
sion: The mean HDL size estimated with DLS constitutes a better
predictor for subclinical carotid atherosclerosis than the convention-




Green synthesis of gold nanoparticles with aminolevulinic acid
of: A novel theranostic agent for atherosclerosis
Karina O. Goncalves, Monica N. Silva, Leticia B. Sicchieri,
Lilia C. Courrol
Unifesp, Diadema, SP, Brazil
Introduction: In this study, ALA gold nanoparticles (ALA:AuNPs)
functionalized with polyethylene glycol (PEG) were synthetized and
administered to rabbits to evaluate its use in clinical practice as
theranostic agent for atherosclerosis. This was done by measuring the
porphyrin ﬂuorescence extracted for the rabbit's blood and feces. An
increase in the blood and feces porphyrin emission after ALA:AuNPs
administration suggests that ALA was incorporated by the gold
nanoparticles, its structure was preserved, and a rapid conversion into
endogenous porphyrins occurred, overloading the synthetic pathway
that lead to the PPIX accumulation. Results: The results show that the
functionalized gold nanoparticles reached atheromatous plaques and its
ALA was converted to PPIX. The selective accumulation of PPIX in
plaques provides a contrast between control animals and those with
atherosclerosis. Conclusions: An increase in the blood and feces
porphyrin emission after ALA:AuNPs administration suggests that ALA
was incorporated by the gold nanoparticles, its structure was preserved,
and a rapid conversion into endogenous porphyrins occurred, over-
loading the synthetic pathway that lead to the PPIX accumulation. The
high accumulation of PPIX in tissues is thought to be the result of
uncontrolled cell proliferation that accompanied the growth of athero-
matous plaques. This ﬁnding indicated that ALA:AuNPs can aid in the
early diagnosis and therapy of atherosclerosis with high sensitivity.
doi:10.1016/j.bbacli.2015.05.038
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High-density lipoprotein (HDL) phospholipid content and
cholesterol efﬂux capacity are reduced in patients with low
HDL-cholesterol and subclinical atherosclerosis
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Introduction: Low HDL-cholesterol (hypoalphalipoproteinemia)
is considered an independent risk factor for atherosclerosis. This
inverse relationship has been attributed to different protective
properties, such as cholesterol efﬂux, inhibition of platelet aggrega-
tion, and their antioxidant and anti-inﬂammatory activities. Thus, we
explored the association between functions of HDL in patients free of
cardiovascular disease and hypoalphalipoproteinemia or atheroscle-
rotic burden. Methods: Study participants were classiﬁed according
to their plasma HDL-cholesterol levels: below the 10th percentile, a
group with low HDL-C (LH; ≤32 mg/dL; n = 33), between percen-
tiles 40 and 60, intermediate group (IH; 40–67 mg/d; n = 33) or
above the 90th percentile, a group with high levels of HDL-C (HH;
≥78 mg/d; n = 35). The chemical composition of HDL, particle size,
cholesterol efﬂux capacity, antioxidant activity, susceptibility to
oxidation, anti-inﬂammatory activity and ability to inhibit platelet
aggregation were measured in 101 patients. Intima–media thickness
of the carotid arteries (CIMT) was determined by high-resolution
ultrasonography. Results: The LH group was associated with
increased CIMT (0.72 ± 0.3 vs. 0.61 ± 0.20 in IH and 0.65 ± 0.15 in
HH; p ≤ 0,001), increased HDL-triglyceride (4 ± 2% vs. 4 ± 2% in IH
and 3 ± 1% in HH, p ≤ 0.001), reduced HDL-phospholipid (12 ± 4%
vs 14 ± 5% in IH and 13 ± 3% HH, p = 0.035), reduced size of HDL
particle (7.33 ± 0.33 nm vs. 7.72 ± 0.45 nm in IH, and 8.49 ±
0.42 nm in HH, p ≤ 0.001), and reduced cholesterol efﬂux capacity
(9 ± 3% vs. 12 ± 3% in IH and 11 ± 4% in HH, p ≤ 0.001).
CIMT N 1 mm was associated with reduced HDL size (7.55 ±
0.49 nm vs. 7.89 ± 0.64 nm, p ≤ 0.001), antioxidant activity (37
(23)% vs 49 (42)%, p = 0.018), and reduced cholesterol efﬂux
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capacity (31 ± 14% vs. 40 ± 14%, p = 0.02).We found a statistically
no signiﬁcant difference for the other functional features or HDL
properties between the groups. Conclusions: Small HDL particles,
low HDL phospholipid content and decreased cholesterol efﬂux
capacity were related to magnitude of subclinical atherosclerosis and
hypoalphalipoproteinemia in a primary care population.
doi:10.1016/j.bbacli.2015.05.039
A40880
Peri/epicellular protein disulﬁde isomerase reshapes vascular
architecture to counteracts constrictive remodeling
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Whole-vessel remodeling critically determines lumen caliber in
vascular (patho)physiology and is reportedly redox-dependent. We
hypothesized that cell-surface pool of the endoplasmic reticulum
(ER) redox chaperone Protein Disulﬁde Isomerase-A1 (peri/epi-
cellular = pecPDI), known to support thrombosis, also regulates
disease-associated vascular architecture. In human coronary athero-
mas, PDI expression inversely correlated with constrictive remodel-
ing and plaque stability. In rabbit iliac artery overdistension model,
there was unusually high PDI upregulation (~25-fold vs. basal
14 days post-injury), involving both intracellular and pecPDI.
Silencing PDI by siRNA in vitro induced ER stress markers
upregulation and apoptosis (assessed by TUNEL assay). PDI knock-
down also upregulated proliferation marker PCNA and decreased
differentiation marker calponin-C. In contrast, pecPDI neutralization
with anti-PDI antibodies (PDIAb) did not enhance ER stress or
apoptosis. In vivo pecPDI neutralization with PDIAb-containing
perivascular gel from days 12–14 post-injury promoted ca. 25%
decrease in maximally dilated arteriographic vascular caliber and
corresponding whole-vessel circumference loss at optical coherence
tomography, without changing neointima, suggesting constrictive
remodeling. This was accompanied by decreased oxidant generation
and nitrogen oxide production. Constrictive remodeling was corrob-
orated by marked changes in collagen organization, switching from
circumferential to radial ﬁber orientation and to more rigid ﬁber
type. Cytoskeleton architecture was also disrupted, with loss of stress
ﬁber coherent organization and switch from thin to medium-
thickness actin ﬁbers, all leading to impaired viscoelastic ductility.
Total and PDI-associated expressions of beta1-integrin, as well as
cell-surface reduced beta1-integrin levels, were diminished after
PDIAb treatment, implicating beta1-integrin as a likely pecPDI target
during vessel repair. Integrin signaling is a master regulator of
mechanobiology connecting the extracellular matrix environment to
focal adhesion and actin-cytoskeleton. Indeed, FAK phosphorylation,
a downstream beta1-integrin effector, was decreased by PDIAb. Thus,
PDI is highly upregulated after injury and reshapes matrix and
cytoskeleton architecture to support an anticonstrictive remodeling
effect. Such ﬁndings suggest an important role for PDI in lumen




Biochemical and histopathological parameters analyzed
in rabbits fed a diet enriched with fat/sucrose/cholesterol
and treated with vitamin D
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Introduction: Low levels of Vitamin D increase risk of cardiovas-
cular diseases. This study aims to assess the effects of vitamin D in an
experimental model of rabbits fed a diet enriched with fat/sucrose/
cholesterol (FSC). Methods: The rabbits were fed a chow enriched
with fat 10%/sucrose 40%/cholesterol 0.5% for three months and
thereafter, the chow were substituted for FSC with cholesterol 0.1%
or standard chow for more 3 months. The following groups were
formed: I — FSC 0.5/0.1%; GII — FSC 0.5/0.1% + Vit D 1000 IU/day;
GIII — FSC 0.5%/ standard chow (SC) and GIV — FSC 0.5%/ standard
chow+ 1000 IU of Vit D/day. In periods of 0, 3 and 6 months the
following parameters were evaluated: weight, lipid proﬁle and
serum glucose. After 6 months the animals were euthanized and
the aortas were removed for atheroma plaques analysis. Statistical
analysis was performed by Kruskal–Wallis non-parametric tests
followed by Dunn's test. Results: After 6 months, the following
values were observed, respectively, in groups I, II, III and IV: total
cholesterol (mg/dL):420 ± 128; 363 ± 119; 149 ± 136; 162 ± 132.
Triglycerides(mg/dL): 172 ± 58; 202 ± 79; 74 ± 24; 63 ± 13. Glu-
cose (mg/dL):97 ± 5; 92 ± 13; 100 ± 18; 106 ± 11. Plaques in
aorta(%): 83 ± 24,62; 84,64 ± 23,22; 15,38 ± 5,95; 24,11 ± 8,81.
Intima/media ratio in arch aorta: 2.98 ± 2.16; 2.57 ± 1.06; 2.74 ±
1.22; 1.35 ± 0.39*. Thoracic aorta: 2.13 ± 1.15; 1.80 ± 1.05; 1.54 ±
0.52; 1.48 ± 0.42. Abdominal aorta: 1.73 ± 0.55; 2.06 ± 1.23; 1.59 ±
0.41; 1.15 ± 0.47. The histopathological aspects of aortas in groups
III and IV were more ﬁbrous than in groups I and II, independently of
vitamin D treatment, however, lower intima/media rate was
observed in the group IV that had received the standard diet and
vitamin D. Conclusion: The normalization of the diet improved the
lipid proﬁle and atherosclerotic plaques in aorta, with beneﬁcial
effect of vitamin D.
doi:10.1016/j.bbacli.2015.05.041
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Comparison of coenzyme Q10 and herbal Withania somnifera
supplements on fatigue parameters and biochemical proﬁle in
dyslipidemic patients with statin in chronic use
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Introduction: The statin class of drugs is the ﬁrst choice in
dyslipidemic patients, to reduction of plasma cholesterol levels,
especially LDL (low density lipoprotein) for the prevention of
cardiovascular disease (CVD). However, fatigue is a side effect in
some patients, possibly by inhibiting melovanato conversion to
coenzyme Q10 (CoQ10), a cofactor in the electron transport chain for
the energy formation, in the same cascade of cholesterol formation.
CoQ10 supplementation helps reduce the effects caused by contin-
uous use of statins. In traditional Chinese Medicine, the Withania
somnifera (or Ashwagandha), is considered an adaptogen herbal and
indicated for fatigue and hipocholesterolemic use. Methods: In this
AbstractsS14
